Kelly Schick
Vermögen: 475 827 $ am 31.05.2026
Vermögen: 475 827 $ am 31.05.2026
Kelly A. Schick is Vice President-Account Management at ScripNet LLC since 2012.
Ms. Schick is Chief People Officer at C4 Therapeutics, Inc. since 2021.
Former roles include Head-Global Talent at Bristol Myers Squibb Co. and Chief Human Resources Officer & Senior VP at AMAG Pharmaceuticals, Inc. Education includes undergraduate studies at Boston University and graduate studies at The Curtis L.
Carlson School of Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.02.2026 | 108’885 ( 0.1% ) | 475 827 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| C4 THERAPEUTICS, INC. | Personalreferent | 12.01.2021 |
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services Provides pharmacy benefit management electronic processing services | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| AMAG PHARMACEUTICALS, INC. | Personalreferent | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services Provides pharmacy benefit management electronic processing services | Technology Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Curtis L. Carlson School of Management
The Curtis L. Carlson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen